The following allergy tests are covered benefits:
1. IgE Specific Antibody (e.g., RAST, micro-Elisa, immunocap) if clinically
indicated for history of severe urticaria, hives, or severe allergy, when skin
testing is inappropriate.
2. Skin tests (scratch, intradermal, pricks)
3. Patch application tests
4. Drug Provocation testing
5. Skin Endpoint Titration (SET). Skin endpoint titration is effective for
quantifying patient sensitivity and for providing a safe starting dose for
immunotherapy. SET has not been shown to be an effective guide to a
final therapeutic dose.
6. Nitric Oxide Breath Analysis for the management of asthma.
The following services have not been proven to be effective in diagnosing
and/or treating allergies, and are not covered benefits:
1. Cytotoxicity testing (Bryan's test)
2. Urine autoinjection (autogenous urine immunization)
3. Provocation testing and neutralization therapy for food allergy
(intracutaneous, subcutaneous or sublingually). Also called
Intracutaneous Progressive Dilution Food Test (IPDFT).
4. Antigen leukocyte cellular antibody test (ALCAT) for all indications
including but not limited to testing for food allergies or intolerance
(chemical sensitivities) and as a tool to establish elimination diets.
5. Electrodermal testing or electro-acupuncture*
6. Applied kinesiology or muscle strength testing of allergies
7. Reaginic pulse testing or pulse testing for allergies
8. Total serum immunoglobulin G (IgG), immunoglobulin A (IgA) and
immunoglobulin M (IgM)
9. Testing of specific IgG antibody (e.g., by RAST or ELISA testing)
10. Lymphocyte subset counts
11. Lymphocyte function assay
12. Lymphocyte transformation test (LTT), also known as lymphocyte
proliferation test and metal ion testing for metal-induced hypersensitivity
response.
13. Cytokine, cytokine receptor assay and Th1/Th2 cytokine ratio
14. Natural Killer (NK) cell assay or activity
15. Food immune complex assay (FICA)
16. Leukocyte histamine release testing
17. Body chemical analysis
18. Sublingual immunotherapy (SLIT) as an alternative way to treat allergies
without injections. SLIT is not FDA approved in the United States
19. Nitric Oxide Breath Analysis for the diagnosis of asthma
*Note: Acupuncture may be covered with a rider for some commercial plans.
DESCRIPTION
Allergy testing, evaluations, and immunotherapy are eligible for coverage
according to the schedule of covered services in plan documents. Testing or
treatment methods not considered as standard medical procedures are not eligible
for coverage.
No comments:
Post a Comment